Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
about
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early deathBetaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sitesModelling neuroinflammatory phenotypes in vivoTargeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory diseaseTransforming growth factor-beta 1 induces antigen-specific unresponsiveness in naive T cellsTGF-beta: a mobile purveyor of immune privilegeEffects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in miceTherapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infecThe FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse developmentTransforming growht factor β1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetodermaMechanisms and modulation of intestinal epithelial repair.Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target geneTGF-β1 of no avail as prognostic marker in lyme diseaseDose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesionsInteraction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10.The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions.Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma.A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.Adenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation.Cytokine modulation in sepsis and septic shock.Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in miceInduction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis.Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout miceCombined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells - chemically injured keratocyte reaction.Expression of nitric oxide synthase and transforming growth factor-beta in crush-injured tendon and synoviumα7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin NeurotoxicityType I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repairAccumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1.Transforming growth factor-beta 1 null mice. An animal model for inflammatory disordersTransforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease.Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.Influenza virus neuraminidase activates latent transforming growth factor beta.In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta.Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal DialysisPostoperative Crohn's disease.Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytesReversal of acute and chronic synovial inflammation by anti-transforming growth factor betaTransforming growth factor beta: the good, the bad, and the uglyTransforming growth factor-beta 1 regulates axon/Schwann cell interactions.
P2860
Q24563654-E974AC98-A7CF-4208-9536-D5AA4CC2492AQ24673586-E96B0874-38B6-4BB4-B389-D476605C0D55Q24796385-9ADAA38D-2C78-4E01-A2A7-E35DAABB90ECQ28202655-A6D12CEC-9401-41D9-A6A7-5C7542856EA0Q28245571-7650D7D4-02C8-4212-92E4-2C05CACA2E3CQ28263622-2E29C1A4-4BDF-41F7-9EFF-2935A69D0CF6Q28343163-30B1C47F-9138-4C8D-84AA-716D3C6B07ACQ28369588-3F1F1578-26AB-4E78-982C-DCDA75B12BE0Q28542654-24E6F430-3909-4EA3-96B1-8400D0FDA007Q29036703-DA53DE1C-A176-45AF-B58B-94C0ABB94DC5Q32099554-70F4669C-BFFB-4B05-BE93-56F4A7F82165Q33247465-ACA0642A-76AF-4E52-BA57-1A7C6CD2A020Q33710542-8CE163B5-A83B-49C4-BC0D-0602CAD88A1CQ33805469-8FC38AFA-02DD-40F4-A751-4A06EEDACBB5Q33919124-7D677E22-6DC4-44F7-A43D-E1828C7311FBQ34002369-C9E183A5-0F60-45C0-9178-ECD03F39E2CEQ34083587-0623EEB4-6700-4B32-8306-0BC88EA6652EQ34186627-EB8E0395-5E35-428A-A016-DFCA7094AAD9Q34192675-B07D307E-E637-4D00-8BE8-4C73FB838F89Q34463886-AC590FB8-ACCE-4882-A6A8-91E614B8F3A1Q34768553-2EC5E925-2073-470A-84E0-53CA6BEA1F74Q35132348-34803E52-EA0C-44AA-8DFF-5E3DE7F9D7A2Q35379930-EAC0FBE8-1C96-4B30-9097-1F4567841100Q35398178-7A13DAB6-2E6A-436E-BB78-4A6FBD9753E2Q35531737-5F947F55-8A61-4994-9B1D-E96CE55F706DQ35609204-C983D7FC-12FB-4EB8-BB18-41CDF1A44C99Q35749490-9A067453-E836-414B-A8F3-E4E7763ED612Q35765279-AEC125FC-9BE5-4EF1-BD66-504880C6B39AQ35796314-9627F95D-37F5-4306-AA30-E75954051AE7Q35797879-0A47850B-5AC6-495B-99DF-E7E38C0AD750Q35832956-2BB3754A-A4EE-4BAE-BB42-25256E933BB1Q35843492-CAB0A3C3-D977-4E33-AFE7-7F19253A69EFQ35873608-A0D44AC3-C967-4C76-8915-D5C04759768EQ36107522-657B637D-4FFC-4F9D-B64E-4740E3BE6FE6Q36204135-42F9A5EC-061C-4751-AA70-AE4227EE1DD7Q36207261-213D9876-D740-4E80-90DD-2DEB979F9D17Q36305926-D708FF7E-A752-4647-A287-97866A0DCFBAQ36361126-9D5228BE-066B-4B79-B72B-B38DE14B625EQ36363951-482C05DA-9154-4069-8B2F-FE8E0CC0FA14Q36382479-5DDC2DD0-31C4-4104-A361-6EE89CC7A10A
P2860
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@ast
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@en
type
label
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@ast
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@en
prefLabel
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@ast
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@en
P2860
P356
P1476
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
@en
P2093
P2860
P2888
P356
10.1007/BF00918135
P577
1992-03-01T00:00:00Z